ATLANTA--(BUSINESS WIRE)--Altea Therapeutics, a leader in advanced transdermal drug delivery systems, announced today senior R&D appointments to strengthen its product development and commercialization capabilities and to align technical operations with the needs of its alliance partners, including Amylin Pharmaceuticals Inc., Eli Lilly and Company, and Hospira, Inc.
